1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Cancer Testing Market in the US 2015-2019

Cancer Testing Sector: Forecast until 2019 in the US

  • November 2015
  • 55 pages
  • ID: 4339140
In this report:
The colorectal cancer testing market in the US was valued at $##.## billion in 2014 and is expected to reach $##.## billion by 2019, growing at CAGR of ##.##%.
The other cancer testing market in the US was valued at $##.## billion in 2014 and is expected to reach $##.## billion by 2019, growing at CAGR of ##.##%.

Summary

Table of Contents

Search Inside

Cancer Testing Market in the US 2015-2019

Covering: Market value and forecast of the cancer testing sector in the USA and segmentation by technique, containing genetic testing and conventional testing. The study discusses the main drivers influencing market increase and the opportunities faced by the sellers and the industry as a whole. The most important dealers evaluated in the analysis are Abbott Diagnostics, Agilent Technologies, Beckman Coulter, and Roche Diagnostics.

Market outlook of the cancer testing sector in the USA

The sector in the USA is experiencing a lot of transformation in healthcare coverage, which have led to increased accessibility to healthcare, and thereby facilitating early diagnosis, preventive medicine, and personalized medicine. The growth in genetic testing for cancer by end-user segments including hospitals, diagnostic laboratories, and academics and research institutes are anticipated to propel the market increase.

Research firm anticipates the cancer diagnostics sector in the USA to grow at a steady rate, posting a compound annual growth rate (CAGR) of over 9% during the projection horizon.

Changes in healthcare system is one of the main drivers influencing the market increase. The number of the US citizens covered under healthcare insurance has increased tremendously and today about 19 million citizens in the USA have insurance coverage. Also, big companies offer healthcare insurance policies to their employees, which will support the increase of the market.

Division of the cancer testing sector in the USA by technique

- Genetic testing

- Conventional testing

The year 2014 saw the dominance of conventional testing segment, accounting for a market share of more than 76.0 percent and this industry segment is predicted to remain at the top through 2019.

Both genetic testing and conventional testing techniques are used for testing different types of cancer, including breast cancer, colorectal cancer, prostate cancer, and others.

What is the current competitive panorama? Who are the main vendors?

The cancer testing sector in the USA marks the existence of various small and medium sized dealers offering a diversified product portfolio. Big corporations are acquiring small and medium-sized manufacturers to improve their product portfolio, which is adding to the competition.

Best merchants in this sector are -

Other main sellers included in this business report are Affymetrix, Bio-Rad Laboratories, Cardinal Health, Cytyc, Fujirebio Diagnostics, Johnson & Johnson, Pathway Genomics, QIAGEN, Quest Diagnostics, Quidel, and Rosetta Genomics.

Growth drivers, opportunities, and upcoming trends: Cancer testing

Market research company's analysts highlight the use of mass spectrometer, an extremely sophisticated instrumentation technology, which provide accurate results with infinitesimal amounts of material and does not even require specially purified samples.

This industry report offers a number of factors providing to the adoption, limitations, and opportunities of the cancer testing sector in the US. It also provides an analysis of each factor and an estimation of the extent to which the factors are likely to impact the worldwide sector increase.

What are the main questions answered?n the market research

contain

- What will the market value and the increase rate be in 2019?

- What are the most significant drivers yielding the cancer testing sector in the USA?

- What are the main segment trends affecting the growth of the cancer testing sector in the USA?

- What are the conditions to market growth?

- Who are the main vendors in the cancer testing sector in the USA?

- What are the opportunities in this industry and segment risks faced by the sellers in the cancer testing sector in the USA?

- What are the main outcomes of the Porter 5 forces analysis of the cancer testing sector in the USA?

Research company also provides customization on reports established on particular client requirement.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

  • $ 6995
  • Industry report
  • July 2018
  • by GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast CancerSummaryBreast cancer remains a major global healthcare ...

Digital Landscape: Breast Cancer

Digital Landscape: Breast Cancer

  • $ 6000
  • Industry report
  • September 2018
  • by GlobalData

Digital Landscape: Breast CancerSummary"Digital Landscape: Breast Cancer", analyzes digital activities undertaken by pharma in support of therapies for Breast Cancer.- The report includes digital activities ...

Breast Cancer Diagnostic and Drug Technologies: Global Markets

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • $ 5500
  • Industry report
  • May 2018
  • by BCC Research

Report Scope:This report is an update to Breast Cancer Diagnostics and Therapeutics Market Report-HLC106B.The objective of the current report is to provide the readers with updated market estimates fo ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on